BIOLASE, Inc.

Rentabilité sur six mois: 0%
Rendement en dividendes: 0%
Secteur: Healthcare

0.0155 $

0 $ 0%
0.0155 $
0.0908 $

paper.min_max_per_year

Calendrier des promotions BIOLASE, Inc.

À propos de l'entreprise BIOLASE, Inc.

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Paramètres de base

IPO date
1992-11-13
ISIN
US0909114052
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0.7874
Дивиденд ао
229.7
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 0.0302 10
P/BV -6 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA -58.78 0
ROE 8353.04 10
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0.6667 6.67
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.9865 10
Debt/Ratio 0.4255 10
Debt/Equity -143.11 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 30.06 5
Rentabilité Ebitda, % 3.69 1
Rentabilité EPS, % -16.09 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.0155 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.0155 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.0155 $ 0.0155 $ 0.0155 $ 0 % 0 % 0 %
common.calendar.number_days.90d 0.0155 $ 0.0155 $ 0.0155 $ 0 % 0 % 0 %
common.calendar.number_days.180d 0.0155 $ 0.0155 $ 0.0155 $ 0 % 0 % 0 %
common.calendar.number_days.1y 0.06 $ 0.0155 $ 0.0908 $ -74.17 % 0 % 0 %
common.calendar.number_days.3y 3.7 $ 0.0155 $ 700 $ -99.58 % 0 % 0 %
common.calendar.number_days.5y 0.421 $ 0.0155 $ 700 $ -96.32 % 0 % 0 %
common.calendar.number_days.10y 0.0155 $ 0.0155 $ 700 $ 100 % 0 % 0 %
common.calendar.number_days.ytd 0.0155 $ 0.0155 $ 0.0155 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. John R. Beaver President, CEO & Director 377.53k 1961 (64 année)
Ms. Jennifer Bright Chief Financial Officer 355.98k 1972 (53 année)
Mr. Steven Sandor Chief Operating Officer 336.39k 1981 (44 année)
Mr. Michael C. Carroll Corporate Secretary N/A 1972 (53 année)

Informations sur l'entreprise

Adresse: United States, Foothill Ranch. CA -, 27042 Towne Centre Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.biolase.com